| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |